MYC - MYC proto-oncogene, bHLH transcription factor Gene
Also Known as c-Myc
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 694626
About MYC
Primary_assembly 8: 128,099,624-128,107,320 forward strand.Mmul_10:CM014343.1
This gene has 2 transcripts (splice variants), 231 orthologues and 2 paralogues.
MYC Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001142873.1 | NP_001136345.1 | myc proto-oncogene protein |
MYC Protein Structure
Myc_N
Myc_N: pfam01056 (1 - 344)
bHLHzip_c-Myc
bHLHzip_c-Myc: cd11458 (350 - 433)
- 0
- 100
- 200
- 300
- 400
- 439 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
myc proto-oncogene protein |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(1)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-17381A | Idarubicin | 99.89% | Yes |
Clinical Phase
Bioactive Molecules
(22)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase |
|---|---|---|---|---|
| HY-172113 | H122 | 98.33% | Phase 4 | |
| HY-12863 | Pelabresib | Inhibitor | 99.95% | Phase 3 |
| HY-113225 | Guanosine triphosphate | / | Phase 3 | |
| HY-111784 | Inobrodib | Inhibitor | 99.95% | Phase 2 |
| HY-153356 | MRT-2359 | Inducer | 99.98% | Phase 2 |
| HY-13241 | Ralimetinib dimesylate | 99.97% | Phase 2 | |
| HY-X0009 | Tambiciclib | 99.68% | Phase 2 | |
| HY-13032B | Molibresib besylate | 97.04% | Phase 2 | |
| HY-109050 | Alobresib | Inhibitor | 98.04% | Phase 2 |
| HY-X0009A | Tambiciclib dimaleate | 99.53% | Phase 2 | |
| HY-185051 | OTX-2002 | / | Phase 2 | |
| HY-15163A | Zotiraciclib hydrochloride | Inhibitor | / | Phase 2 |
| HY-16291 | APTO-253 | 99.74% | Phase 1 | |
| HY-145898 | WBC100 | Inhibitor | 95.01% | Phase 1 |
| HY-136938 | NEO2734 | Inhibitor | 99.63% | Phase 1 |
| HY-16366 | Briciclib | 99.45% | Phase 1 | |
| HY-103019B | (-)-Enitociclib | 99.85% | Phase 1 | |
| HY-117286 | (S)-JQ-35 | 99.46% | Phase 1 | |
| HY-137849 | RK-582 | Inhibitor | 98.05% | Phase 1 |
| HY-112316 | BAY1238097 | Inhibitor | 99.02% | Phase 1 |
| HY-16291A | APTO-253 hydrochloride | Inhibitor | / | Phase 1 |
| HY-103019BR | (-)-Enitociclib (Standard) | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(306)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-12702 | 10058-F4 | Inhibitor | 99.90% | Unkown |
| HY-80013 | THZ1 | Inhibitor | 99.84% | Unkown |
| HY-107738 | Guggulsterone | 99.83% | Unkown | |
| HY-134582 | dCBP-1 | 99.37% | Unkown | |
| HY-112929 | DT-061 | Activator | 99.95% | Unkown |
| HY-103019 | Enitociclib | 99.89% | Unkown | |
| HY-126477 | NNK | 99.97% | Unkown | |
| HY-19735 | KJ Pyr 9 | Inhibitor | 99.24% | Unkown |
| HY-120929 | BI8622 | Inhibitor | 98.16% | Unkown |
| HY-129937A | GNE-987 | Inhibitor | 99.98% | Unkown |
| HY-162318 | MYC degrader 1 | Degrader | 99.61% | Unkown |
| HY-139361 | Sulfopin | Inhibitor | 99.82% | Unkown |
| HY-N0330 | Momordin Ic | 99.78% | Unkown | |
| HY-N3005 | Britannin | 99.93% | Unkown | |
| HY-124675 | MYCMI-6 | 98.57% | Unkown | |
| HY-123954 | BTX-A51 | 98.58% | Unkown | |
| HY-N2068 | Didymin | Inducer | 99.96% | Unkown |
| HY-134761 | EN4 | Inhibitor | 96.29% | Unkown |
| HY-129600 | MYCi361 | Inhibitor | 99.95% | Unkown |
| HY-174228 | I3IN-002 | 99.35% | Unkown | |
| HY-145669 | DIF-3 | 99.84% | Unkown | |
| HY-N0704 | Agrimol B | 99.75% | Unkown | |
| HY-124447 | BTYNB | 98.0% | Unkown | |
| HY-153713 | MYC-RIBOTAC | 98.17% | Unkown | |
| HY-172158 | ALKBH5-IN-5 | 99.66% | Unkown | |
| HY-80013A | THZ1 Hydrochloride | Inhibitor | 99.06% | Unkown |
| HY-100996 | 10074-G5 | Inhibitor | 99.63% | Unkown |
| HY-139330 | MGH-CP1 | Inducer | 99.56% | Unkown |
| HY-112296 | T025 | 99.64% | Unkown | |
| HY-114208A | BI-9321 trihydrochloride | Antagonist | 99.83% | Unkown |
| HY-120028 | GNE-207 | Inhibitor | 99.94% | Unkown |
| HY-P0312 | c-Myc Peptide TFA | 99.97% | Unkown | |
| HY-N2534 | Karanjin | 99.96% | Unkown | |
| HY-148837 | GT19630 | 98.85% | Unkown | |
| HY-149230 | USP28-IN-4 | Inhibitor | 99.35% | Unkown |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | 41.20% | Unkown | |
| HY-100669 | Mycro 3 | Inhibitor | 98.11% | Unkown |
| HY-13250 | Silvestrol aglycone | 99.95% | Unkown | |
| HY-173523 | KI-CDK9d-32 | 99.03% | Unkown | |
| HY-103019A | (±)-Enitociclib | 99.23% | Unkown | |
| HY-144878 | VPC-70619 | Inhibitor | 99.93% | Unkown |
| HY-12703 | KSI-3716 | Inhibitor | 98.98% | Unkown |
| HY-135691 | hnRNPK-IN-1 | 97.0% | Unkown | |
| HY-133121 | WDR5-IN-1 | 98.0% | Unkown | |
| HY-107194 | NSC12 | / | Unkown | |
| HY-19759 | SRT 2183 | 98.06% | Unkown | |
| HY-149209 | LL-K8-22 | 99.06% | Unkown | |
| HY-162919 | YK-2168 | 98.05% | Unkown | |
| HY-150259 | MDEG-541 | Degrader | 98.68% | Unkown |
| HY-153728 | WM-586 | Inhibitor | 98.71% | Unkown |
| HY-171770 | dAurAB5 | 99.03% | Unkown | |
| HY-172825 | KL4-219A | Degrader | 99.85% | Unkown |
| HY-19763 | Ifupinostat | 99.30% | Unkown | |
| HY-122683 | sAJM589 | Inhibitor | 99.47% | Unkown |
| HY-112440 | HZX-02-059 | Inhibitor | 99.40% | Unkown |
| HY-153278 | Q901 | Inhibitor | 98.38% | Unkown |
| HY-160409 | TopBP1-IN-1 | 98.35% | Unkown | |
| HY-22445 | MY05 | Inhibitor | 99.34% | Unkown |
| HY-N10790 | RA-V | 99.85% | Unkown | |
| HY-112056 | DIM-C-pPhCO2Me | 99.47% | Unkown | |
| HY-114189 | GW284543 | Inhibitor | 99.94% | Unkown |
| HY-163828 | PPA24 | 98.09% | Unkown | |
| HY-N0863 | Methyl protodioscin | 99.67% | Unkown | |
| HY-N8146 | Bruceantinol | Inhibitor | 98.89% | Unkown |
| HY-125236 | ZEN-3694 | Inhibitor | 99.74% | Unkown |
| HY-168439 | HLB-0532259 | Degrader | 98.30% | Unkown |
| HY-147291 | VPC-70063 | 99.92% | Unkown | |
| HY-153278A | Q901 TFA | Inhibitor | / | Unkown |
| HY-N10549 | Gigantol | 99.79% | Unkown | |
| HY-154847 | WM-662 | Inhibitor | 99.48% | Unkown |
| HY-119271 | CMLD010509 | 99.11% | Unkown | |
| HY-148836 | c-Myc inhibitor 6 | Inhibitor | 98.04% | Unkown |
| HY-149873 | Anticancer agent 126 | Inhibitor | 98.05% | Unkown |
| HY-W013724 | Inosine-5'-diphosphate disodium | 99.08% | Unkown | |
| HY-W1126235 | DS02312223 | Activator | 98.24% | Unkown |
| HY-113225S5 | Guanosine triphosphate-13C10 dilithium | 99.4% | Unkown | |
| HY-103038 | ML327 | Inhibitor | 98.02% | Unkown |
| HY-112799 | DK419 | Inhibitor | 99.86% | Unkown |
| HY-115590 | JP-11646 | 98.74% | Unkown | |
| HY-111411 | IZCZ-3 | Inhibitor | 99.74% | Unkown |
| HY-117203A | CDK12-IN-E9 | Inhibitor | 99.71% | Unkown |
| HY-113225S3 | Guanosine triphosphate-15N5 dilithium | 99.2% | Unkown | |
| HY-124811 | IRES-C11 | Inhibitor | 98.01% | Unkown |
| HY-126979 | Mycro2 | Inhibitor | 99.81% | Unkown |
| HY-134333 | ICCB280 | Activator | 98.14% | Unkown |
| HY-162318A | MYC degrader 1 TFA | Degrader | 99.36% | Unkown |
| HY-168685 | c-Myc ligand 1 | Inhibitor | 99.93% | Unkown |
| HY-N6747 | Stauprimide | Inhibitor | 99.45% | Unkown |
| HY-145748 | SYUIQ-5 | 99.03% | Unkown | |
| HY-150109A | Purinostat | Inhibitor | 98.04% | Unkown |
| HY-RS08877 | MYC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-133131 | PROTAC BRD4 Degrader-1 | Inhibitor | 99.31% | Unkown |
| HY-124129 | 10074-A4 | Inhibitor | 98.22% | Unkown |
| HY-168428 | CHI-KAT8i5 | 98.00% | Unkown | |
| HY-173119 | SKLB-D18 | 98.06% | Unkown | |
| HY-133138 | Pomalidomide-PEG1-azide | 95.03% | Unkown | |
| HY-111522 | RK-9123016 | Inhibitor | 99.65% | Unkown |
| HY-121418 | Lusianthridin | Inhibitor | 99.21% | Unkown |
| HY-123955 | Casein Kinase inhibitor A86 | 99.26% | Unkown | |
| HY-148452 | eIF4A3-IN-18 | Inhibitor | 99.58% | Unkown |
| HY-156084 | LL-K9-3 | 99.2% | Unkown | |
| HY-162470 | DBPR728 | Inhibitor | 98.11% | Unkown |
| HY-172920 | Wnt/β-catenin-IN-6 | 98.34% | Unkown | |
| HY-176142 | YX0798 | 98.90% | Unkown | |
| HY-N11576 | Secalonic acid D | 99.63% | Unkown | |
| HY-N2276 | Nodakenetin | Activator | 99.66% | Unkown |
| HY-113225S2 | Guanosine triphosphate-13C dilithium | 98.2% | Unkown | |
| HY-125978 | JY-3-094 | Inhibitor | 97.04% | Unkown |
| HY-134975 | NY2267 | Inhibitor | 98.53% | Unkown |
| HY-147651 | β-catenin-IN-4 | Inhibitor | 99.84% | Unkown |
| HY-148446 | eIF4A3-IN-12 | Inhibitor | 99.70% | Unkown |
| HY-149229 | USP28-IN-3 | Inhibitor | 98.26% | Unkown |
| HY-162469 | 6K465 | Inhibitor | 98.61% | Unkown |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-171769 | dAurAB2 | Degrader | / | Unkown |
| HY-173212 | PLK1-IN-13 | / | Unkown | |
| HY-RS08878 | Myc Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-D2188 | IMP-2373 | Chemical | 99.58% | Unkown |
| HY-112316A | (R)-BAY1238097 | 99.07% | Unkown | |
| HY-138632 | PROTAC BRD4 Degrader linker conjugate-1 | Degrader | 98.98% | Unkown |
| HY-101280 | LB-60-OF61 | Inhibitor | 99.25% | Unkown |
| HY-107425B | cis-MZ 1 hydrate | 99.0% | Unkown | |
| HY-112929B | (1S,2S,3R)-DT-061 | 99.77% | Unkown | |
| HY-113225S1 | Guanosine triphosphate-13C10,15N5 tetraammonium solution (100 mM) | 99.98% | Unkown | |
| HY-113225S4 | Guanosine triphosphate-15N5,d14 dilithium | 98.4% | Unkown | |
| HY-132941 | CFT-2718 | 99.87% | Unkown | |
| HY-147261 | B026 | Inhibitor | / | Unkown |
| HY-147973 | IZTZ-1 | 99.47% | Unkown | |
| HY-148443 | eIF4A3-IN-9 | Inhibitor | 99.71% | Unkown |
| HY-148444 | eIF4A3-IN-10 | Inhibitor | 97.87% | Unkown |
| HY-148445 | eIF4A3-IN-11 | Inhibitor | 99.24% | Unkown |
| HY-148448 | eIF4A3-IN-14 | Inhibitor | 99.81% | Unkown |
| HY-148449 | eIF4A3-IN-15 | Inhibitor | / | Unkown |
| HY-148450 | eIF4A3-IN-16 | Inhibitor | 99.96% | Unkown |
| HY-148451 | eIF4A3-IN-17 | Inhibitor | 99.56% | Unkown |
| HY-151884 | FUBP1-IN-2 | Inhibitor | 99.26% | Unkown |
| HY-162796 | TS-2 | 98.27% | Unkown | |
| HY-185310 | MKI-2 | Inhibitor | / | Unkown |
| HY-W011616 | Cardionogen 1 | Inhibitor | 99.21% | Unkown |
| HY-174577 | Human MYC mRNA | 86.9% | Unkown | |
| HY-N19791 | 6-Methoxymellein | Inhibitor | 97.69% | Unkown |
| HY-101280A | LB-60-OF61 hydrochloride | Inhibitor | / | Unkown |
| HY-128761 | CBP/p300-IN-2 | Inhibitor | / | Unkown |
| HY-158062 | LC-1-40 | / | Unkown | |
| HY-182242 | AGB-374 | Inhibitor | / | Unkown |
| HY-111165 | SNX-7081 | / | Unkown | |
| HY-111537 | rel-AZ5576 | Inhibitor | / | Unkown |
| HY-10212A | BIIB021 mesylate | / | Unkown | |
| HY-104072 | BRD4-IN-3 | Inhibitor | / | Unkown |
| HY-114189A | GW284543 hydrochloride | Inhibitor | / | Unkown |
| HY-114208 | BI-9321 | Antagonist | / | Unkown |
| HY-115541 | BRD4-IN-41 | Inhibitor | / | Unkown |
| HY-115663 | C620-0696 | / | Unkown | |
| HY-115797 | LQFM030 | / | Unkown | |
| HY-115832 | Ap44mSe | / | Unkown | |
| HY-120750 | A 62176 hydrochloride | / | Unkown | |
| HY-121444 | MYRA-A | / | Unkown | |
| HY-121917 | Ro 31-7837 | / | Unkown | |
| HY-122352 | OSU-03013 | / | Unkown | |
| HY-122686 | USP25/28-IN-2 | / | Unkown | |
| HY-122860 | SKLB-C05 | / | Unkown | |
| HY-124791 | MMRi6 | 99.70% | Unkown | |
| HY-124792 | MRLB-223 | / | Unkown | |
| HY-125090 | PHA-680626 | / | Unkown | |
| HY-125636 | Mycro1 | Inhibitor | / | Unkown |
| HY-125718 | MLS-2384 free base | / | Unkown | |
| HY-129341 | WP1193 | Inhibitor | / | Unkown |
| HY-129937 | (S)-GNE-987 | Inhibitor | / | Unkown |
| HY-131203 | PROTAC BRD4 Degrader-6 | / | Unkown | |
| HY-136794 | SB-284851-BT | Inhibitor | / | Unkown |
| HY-139885 | c-Myc inhibitor 4 | Inhibitor | / | Unkown |
| HY-141666 | MYC-IN-2 | Inhibitor | / | Unkown |
| HY-143235 | BRD4 Inhibitor-15 | / | Unkown | |
| HY-143471 | WNY0824 | / | Unkown | |
| HY-145843 | c-Myc inhibitor 5 | Inhibitor | / | Unkown |
| HY-146445 | P300 bromodomain-IN-1 | Inhibitor | / | Unkown |
| HY-148838 | c-Myc inhibitor 8 | Inhibitor | / | Unkown |
| HY-148839 | c-Myc inhibitor 9 | Inhibitor | / | Unkown |
| HY-149101 | Inosine-5'-diphosphate | / | Unkown | |
| HY-149228 | USP28-IN-2 | Inhibitor | / | Unkown |
| HY-149495 | CP-07 | Degrader | / | Unkown |
| HY-149513 | EP12 | / | Unkown | |
| HY-149735 | BET-IN-20 | / | Unkown | |
| HY-150683 | NC-III-49-1 | Inhibitor | / | Unkown |
| HY-150684 | GXH-II-052 | Inhibitor | / | Unkown |
| HY-151471 | Anticancer agent 84 | Inhibitor | / | Unkown |
| HY-152471 | Eleven-Nineteen-Leukemia Protein IN-3 | Inhibitor | / | Unkown |
| HY-154839 | c-Myc inhibitor 10 | Inhibitor | / | Unkown |
| HY-155153 | CDK9-IN-24 | / | Unkown | |
| HY-155507 | c-Myc inhibitor 11 | Inhibitor | / | Unkown |
| HY-155508 | c-Myc inhibitor 12 | Inhibitor | / | Unkown |
| HY-156673 | m-Se3 | Inhibitor | / | Unkown |
| HY-15947G | Ravoxertinib (GMP) | Inhibitor | / | Unkown |
| HY-159728 | PROTAC PRMT3 degrader 1 | Degrader | / | Unkown |
| HY-159756B | KI-MS2-008 | Inhibitor | / | Unkown |
| HY-160549 | c-Myc inhibitor 14 | Inhibitor | / | Unkown |
| HY-160689 | GW694590A | Inhibitor | / | Unkown |
| HY-161826 | Antitumor agent-174 | Inhibitor | / | Unkown |
| HY-162294 | c-Myc inhibitor 13 | Inhibitor | / | Unkown |
| HY-162460 | ERK1/2 inhibitor 10 | Inhibitor | / | Unkown |
| HY-163108 | ATAD2-IN-1 | / | Unkown | |
| HY-16366A | Briciclib sodium | / | Unkown | |
| HY-163679 | PROTAC ERα Degrader-9 | / | Unkown | |
| HY-163774 | WDR5-MYC-IN-1 | Inhibitor | / | Unkown |
| HY-165606 | SB-T-1214 | Inducer | / | Unkown |
| HY-168483 | FTO-IN-13 | / | Unkown | |
| HY-168684 | E3 Ligase Ligand-linker Conjugate 136 | / | Unkown | |
| HY-168886 | Anticancer agent 263 | Ligand | / | Unkown |
| HY-169348 | β-catenin-IN-8 | Inhibitor | / | Unkown |
| HY-169378 | CSI86 | Degrader | / | Unkown |
| HY-169921 | c-Myc inhibitor 15 | Inhibitor | / | Unkown |
| HY-170595 | PROTAC LZK degrader 1 | / | Unkown | |
| HY-170841 | HDAC3/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-170900 | SJ44236 | / | Unkown | |
| HY-171334A | P1D-34 | / | Unkown | |
| HY-171788 | NMT-IN-8 | Inhibitor | / | Unkown |
| HY-172368 | PROTAC CARM1/IKZF3 degrader-1 | / | Unkown | |
| HY-172399 | FTO-IN-14 | / | Unkown | |
| HY-172614 | RK-0080552 | / | Unkown | |
| HY-173062 | BRD4 Inhibitor-40 | Inhibitor | / | Unkown |
| HY-173467 | MTP3 | Degrader | / | Unkown |
| HY-173469 | MYC ligand-1 | Degrader | / | Unkown |
| HY-174255 | WDR5-MYC-IN-2 | Inhibitor | / | Unkown |
| HY-174403 | c-MYC/BCL2 ligand 1 iodide | / | Unkown | |
| HY-175033 | BRD4-IN-11 | Inhibitor | / | Unkown |
| HY-175164 | SVC112 | / | Unkown | |
| HY-175265 | PQ32 | / | Unkown | |
| HY-175771 | STAT3-IN-46 | Inhibitor | / | Unkown |
| HY-175850 | GSK-3β-IN-28 | / | Unkown | |
| HY-175964 | MYC-MAX-IN-1 | Ligand | / | Unkown |
| HY-176019 | Methylcarbamyl PAF C-8 | / | Unkown | |
| HY-176066A | c-Myc inhibitor 16 iodide | / | Unkown | |
| HY-176488 | Y-99 | Inhibitor | / | Unkown |
| HY-176501 | FKBP12 ligand-2 | / | Unkown | |
| HY-176502 | FKBP12 ligand-3 | / | Unkown | |
| HY-177744 | GSPT2 degrader-1 | / | Unkown | |
| HY-177872 | GQC-05 | Inducer | / | Unkown |
| HY-178039 | CDK9-IN-42 | / | Unkown | |
| HY-178045 | MYC-IN-4 | Inhibitor | / | Unkown |
| HY-178172 | AF9/ENL-DOT1L PPI-IN-1 | Inhibitor | / | Unkown |
| HY-178446 | METTL3-IN-11 | Inhibitor | / | Unkown |
| HY-178499 | CDK9-IN-44 | Inhibitor | / | Unkown |
| HY-178858 | PROTAC FLT3/CHK1 Degrader-1 | / | Unkown | |
| HY-178909 | Y502-2304 | / | Unkown | |
| HY-178984 | PI3Kα-IN-28 | / | Unkown | |
| HY-179023 | CDK9-IN-45 | / | Unkown | |
| HY-179267 | FTO-IN-16 | / | Unkown | |
| HY-179525 | DL78 | 99.00% | Unkown | |
| HY-179588 | PROTAC BET Degrader-14 | / | Unkown | |
| HY-179734 | PROTAC BRD4 Degrader-41 | / | Unkown | |
| HY-180124 | CDK8-IN-20 | / | Unkown | |
| HY-180150 | PROTAC BRD4 Degrader-42 | / | Unkown | |
| HY-180355 | SY-5102 | / | Unkown | |
| HY-180886 | ZD-1-186 | Inhibitor | / | Unkown |
| HY-181078 | Cephalotaxine-ester-(R)-1-ethoxy-3-mercaptopropan-2-ol-Ph(3,4OMe) | / | Unkown | |
| HY-181234 | Y502-3888 | / | Unkown | |
| HY-181505 | BRD4-IN-12 | / | Unkown | |
| HY-181514 | STAT3-IN-53 | / | Unkown | |
| HY-181541 | HIT211504993 | / | Unkown | |
| HY-181627 | ETC-501 | 97.40% | Unkown | |
| HY-181669 | P300-IN-6 | Inhibitor | / | Unkown |
| HY-181670 | WH23 | / | Unkown | |
| HY-181729 | PROTAC BET Degrader-15 | / | Unkown | |
| HY-181758 | PROTAC CBP/p300/BRD4 Degrader-1 | / | Unkown | |
| HY-181930 | TNIK-IN-10 | / | Unkown | |
| HY-181957 | KB528 | / | Unkown | |
| HY-182036 | KWZL-7f15 | / | Unkown | |
| HY-182055 | Anticancer agent 309 | / | Unkown | |
| HY-182241 | JR4-187 | / | Unkown | |
| HY-182681 | AV-9606-129 | Inhibitor | / | Unkown |
| HY-182706 | NSC 373981 | Inhibitor | / | Unkown |
| HY-182801 | PROTAC BRD4 Degrader-46 | / | Unkown | |
| HY-182958 | Hsp70TAC BRD4 Degrader-1 | / | Unkown | |
| HY-183070 | CXJ2080 | / | Unkown | |
| HY-183073 | TZ1104 | / | Unkown | |
| HY-183273 | BRD4/AKT-IN-1 | / | Unkown | |
| HY-183643 | RUVBL1/2-IN-1 | / | Unkown | |
| HY-183710 | CDK9-IN-50 | / | Unkown | |
| HY-183770 | LCI40 | Inhibitor | / | Unkown |
| HY-183825 | Eleven-Nineteen-Leukemia Protein IN-4 | Inhibitor | / | Unkown |
| HY-183984 | G-quadruplex ligand 6 | Ligand | / | Unkown |
| HY-183992 | CZL-149 | Inhibitor | / | Unkown |
| HY-184176 | DBCO-PEG3-AP1867 | Chemical | / | Unkown |
| HY-184335 | PROTAC BET Degrader-18 | / | Unkown | |
| HY-184342 | SYC-2863 | / | Unkown | |
| HY-185697 | dIRF4-2 | Inhibitor | / | Unkown |
| HY-186146 | SGI-1776-VHL-02 | 96.67% | Unkown | |
| HY-N15121 | 4-O-Methyl-ascochlorin | / | Unkown | |
| HY-P10418 | VGN50 | Inhibitor | / | Unkown |
| HY-RS08879 | Myc Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W013724S | Inosine-5'-diphosphate-15N4 dilithium | Inhibitor | / | Unkown |
| HY-W800535 | Cryptolepine | / | Unkown | |
| HY-103019AR | (±)-Enitociclib (Standard) | / | Unkown | |
| HY-119271A | (-)-CMLD010509 | / | Unkown | |
| HY-130369 | NSC10010 hydrochloride | / | Unkown | |
| HY-139118 | NSC308848 | / | Unkown | |
| HY-149451 | SYHA1815 | Inhibitor | / | Unkown |
| HY-168326 | Antiproliferative agent-64 | Inhibitor | / | Unkown |
| HY-173172 | MG-002 | / | Unkown | |
| HY-180454 | NUCC-0201642 | / | Unkown | |
| HY-181473 | Antiproliferative agent-75 | / | Unkown | |
| HY-183004 | NCP26 | / | Unkown | |
| HY-N15201 | Betavulgarin | Inhibitor | / | Unkown |
| HY-N15438 | Herbacitrin | Inhibitor | / | Unkown |
| HY-RS18487 | Nol3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W806047 | BRD4 Inhibitor-37 | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991432 | VTX-0811 | / | Unkown | |
| HY-P990850 | Anti-c-myc Antibody (9E10) | Inhibitor | / | Unkown |